Customize your JAMA Network experience by selecting one or more topics from the list below.
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during pregnancy and early infancy can result in severe disease.1-3 Less is known about the immune responses of pregnant women with coronavirus disease 2019 (COVID-19) and the possibility for infant protection. Vaccination of pregnant women with SARS-CoV-2 vaccines in development has begun in the United States in the context of emergency use authorized vaccine deployment for high-risk priority groups and guidance from the US Centers for Disease Control and Prevention Advisory Committee on Immunization Practices and the American College of Obstetrics and Gynecology.4-8 Therefore, it is imperative to better understand the potential of immunization during pregnancy for maternal and infant disease prevention and for the implementation of pandemic control strategies.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Munoz FM. Can We Protect Pregnant Women and Young Infants From COVID-19 Through Maternal Immunization? JAMA Pediatr. 2021;175(6):561–562. doi:10.1001/jamapediatrics.2021.0043
Create a personal account or sign in to: